T 0590/98 ("Radiopharmaceuticals/AMERSHAM PLC") of 30.04.2003
- European Case Law Identifier
- ECLI:EP:BA:2003:T059098.20030430
- Date of decision
- 30 April 2003
- Case number
- T 0590/98
- Petition for review of
- -
- Application number
- 90914225.9
- IPC class
- A61K 51/00
- Language of proceedings
- English
- Distribution
- Distributed to board chairmen and members (B)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- New cores for technetium radiopharmaceuticals
- Applicant name
- Amersham plc
- Opponent name
- The Du Pont Merck Pharmaceutical Company
- Board
- 3.3.02
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 100 1973European Patent Convention Art 104 1973European Patent Convention Art 105 1973European Patent Convention Art 107 1973European Patent Convention Art 108 1973European Patent Convention Art 123(2) 1973European Patent Convention Art 123(3) 1973European Patent Convention Art 54(3) 1973European Patent Convention Art 84 1973European Patent Convention Art 99 1973European Patent Convention R 57a 1973European Patent Convention R 64 1973
- Keywords
- Admissibility of appeal (yes): no evidence of transfer of business
Main request: disclaimer not acceptable under Articles 84 and 123(2) EPC; no reason to suspend the proceedings until decision of the Enlarged Board of Appeal in cases G 0001/03 and G 0002/03
Auxiliary requests 1 to 4: not admissible as reformatio in peius
Apportionment of costs (no) - Catchword
- -
- Cited cases
- G 0004/88G 0009/92G 0004/93G 0001/99T 0004/80T 0434/92T 0653/92T 0659/92T 0426/94T 0298/97T 0451/99T 0507/99T 0724/99
- Citing cases
- T 0446/00
ORDER
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.
3. The respondent's requests for apportionment of costs are dismissed.